Neurocognitive and Psychosocial Outcome of Youths With Autism Spectrum Disorder
1 other identifier
observational
523
1 country
1
Brief Summary
Autism spectrum disorders (ASD) is a common childhood-onset, multi-factorial, highly heritable, clinically and genetically heterogeneous, neurodevelopmental disorder. Due to its high prevalence and severe lifelong impairment without effective prevention and treatment, there is a dearth of investigating its pathogenesis, longitudinal outcome, and biomarkers (endophenotypes). The ultimate goals of this 5-year project are to prospectively investigate the outcome and changes of psychosocial and neurocognitive functions of a cohort of probands with ASD at adolescence and young adulthood as the primary aim; and to test whether structural and functional brain connectivity can be effective endophenotypes of ASD using the unaffected sibling and follow-up designs as the secondary aims.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2014
CompletedFirst Posted
Study publicly available on registry
September 8, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedSeptember 2, 2021
September 1, 2021
5 years
August 27, 2014
September 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnosis of autism
Using Autism Diagnostic Interview-Revised (ADI-R) to assess the developmental and behavioral aspects of autism, including reciprocal social interaction, communication, and repetitive behaviors and stereotyped patterns.
one day
Secondary Outcomes (1)
Diagnosis of autism
one day
Study Arms (2)
ASD group
Subjects with DSM-IV ASD diagnosis
Control group
Controls without lifetime ASD or a family history of ASD
Eligibility Criteria
373 ASD, aged 10-25, from the cohort of ASD established by NRPGM, who consented to this follow-up study at their first assessments in 2007-2011 and 150 age-, and sex-matched TD, at the ratio of 2:1.
You may qualify if:
- ASD participants
- that they have a clinical diagnosis of autistic disorder or Asperger disorder defined by the DSM-IV and ICD-10 criteria, made by board-certificated child psychiatrists and who were clinically diagnosed with ASD confirmed by the ADI-R 7 years ago;
- their ages range from 10 to 25 (i.e., 3-18 years old at the first assessment);
- both parents are Han Chinese;
- who have complete clinical and behavioral data at the 1st assessment;
- participants and their parents consented to participate in this longitudinal study 7 years ago for complete assessments (3 visits of assessments) at follow-up.
You may not qualify if:
- For TD controls:
- comorbidity with DSM-IV-TR or DSM-5 diagnoses of ASD, ADHD, schizophrenia, schizoaffective disorder, delusional disorder, other psychotic disorder, organic psychosis, schizotypal personality disorder, bipolar disorder, depression, severe anxiety disorders or substance use;
- comorbidity with neurological or systemic disorders; and
- having a first degree relative who may have ASD based on family history method assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan Univeristy Hospital
Taipei, Taiwan
Biospecimen
The subjects will receive blood withdrawal. The blood sample will be used for establishing lymphoblastoid cell lines, which will be used for molecular genetic experiments
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Shur-Fen Gau, MD, PhD
National Taiwan University Hospital & College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2014
First Posted
September 8, 2014
Study Start
January 1, 2015
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
September 2, 2021
Record last verified: 2021-09